The 2026 coding year introduced some of the most operationally significant changes gastroenterology practices have seen in recent years. While many groups initially focused on the addition of new CPT codes, the larger impact extends far beyond coding alone. The changes affect reimbursement mechanics, documentation specificity, prior authorization workflows, ASC strategy, site-of-service economics, and overall revenue-cycle performance. For GI practices, the conversation is no longer simply about submitting claims correctly. It is increasingly about protecting revenue through operational precision.
The new GI CPT codes became effective January 1, 2026, following publication in the AMA CPT 2026 code set and subsequent CMS reimbursement guidance. One of the most important additions was CPT 43889 for endoscopic sleeve gastroplasty (ESG), a procedure that previously lacked a dedicated Category I CPT code. Before this change, many practices relied on unlisted procedure codes, leading to inconsistent payer recognition, reimbursement uncertainty, authorization difficulties, and increased denial risk. The addition of a dedicated ESG code represents an important step toward reimbursement standardization and broader commercial payer adoption. Operationally, this may improve clean claim submission and reduce reimbursement variability for practices offering bariatric endoscopy services, although payer adoption remains inconsistent in early 2026 and prior authorization challenges continue to create revenue-cycle risk.
Significant changes were also introduced in anorectal physiology testing. Older CPT codes 91120 and 91122 were deleted and replaced with newer codes designed to better reflect current clinical workflows and documentation standards. The revised coding structure attempts to reduce confusion surrounding dual reporting and bundling while aligning reimbursement more closely with the complexity of the work being performed. However, these updates also increase the importance of coding specificity, as incorrect reporting combinations may trigger National Correct Coding Initiative (NCCI) edits, denials, post-payment audits, or repayment requests.
The financial impact of these changes cannot be understood through RVUs alone. Although CMS finalized the 2026 Physician Fee Schedule with updated conversion factors, actual reimbursement varies significantly based on locality, payer contracts, facility versus non-facility settings, and whether services are performed in physician offices, ambulatory surgery centers (ASCs), or hospital outpatient departments. Increasingly, the larger financial issue is not simply what code is billed, but where the service is delivered and whether the payer recognizes and reimburses the service appropriately. Many practices underestimate how much revenue leakage occurs through authorization failures, payer-policy lag, modifier errors, and site-of-service reimbursement differentials.
GI practices are also experiencing increased documentation scrutiny. Payers are demanding greater specificity regarding procedural indications, lesion characteristics, medical necessity, and distinctions between screening and diagnostic services. This is particularly important in colonoscopy billing, advanced polypectomy procedures, EMR services, and anorectal physiology testing. Poor documentation now carries a much higher risk of down coding, medical necessity denials, and payer recoupments.
Another important development involves continued migration of GI procedures into ambulatory surgery centers. CMS expanded ASC eligibility for selected GI procedures in 2026, continuing a broader healthcare trend toward lower-cost outpatient settings. This reflects increasing “site-of-service reimbursement pressure,” a term referring to payer efforts to shift procedures away from higher-cost hospital outpatient departments and toward ASCs or physician office settings. A procedure performed in a hospital outpatient department may reimburse very differently than the same procedure performed in an ASC. As a result, GI practices increasingly need to think strategically about ownership structure, ASC partnerships, scheduling workflows, staffing, payer contracts, and procedural routing. Coding accuracy alone is no longer sufficient to optimize revenue performance.
Evaluation and management (E/M) reimbursement complexity has also evolved in 2026. CMS continues to recognize the longitudinal complexity involved in managing chronic gastrointestinal diseases such as inflammatory bowel disease, chronic liver disease, obesity, pancreatic disorders, and motility conditions. Many GI physicians may qualify for additional reimbursement through complexity add-on code G2211 when managing ongoing, longitudinal patient relationships that require substantial coordination, counseling, medication management, and continuity of care. However, many practices continue to under-document this complexity or fail to educate providers on appropriate utilization of these codes, resulting in substantial silent revenue leakage.
Ultimately, the 2026 GI coding changes reflect a much larger shift occurring throughout healthcare. CMS and commercial payers are increasingly emphasizing higher specificity, bundled workflows, outpatient migration, utilization management, and operational accountability. For GI practices, financial success is becoming increasingly dependent on the ability to combine accurate coding with payer strategy, provider education, denial prevention, documentation optimization, authorization management, and operational workflow efficiency.
The greatest revenue risk is no longer simply billing incorrectly. It is the silent operational leakage occurring across documentation, modifiers, prior authorizations, payer edits, and site-of-service decisions.
Pract-Eaze
Pract-Eaze works with private practices, health systems, and healthcare technology partners to navigate complex revenue cycle changes and improve financial performance. If you are evaluating how the gastroenterology coding changes 2026 may impact your organization:
📞 (724) 512-5777
✉️ info@pract-eaze.com
🌐 www.pract-eaze.com
Dr. Renu Joshi MD, EMBA, FACOG
OB-GYN | Private Practice Physician | Physician-Entrepreneur
Founder, Pract-Eaze